Cost-effective reimbursement analysis for medical technologies in Europe
Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 20 EU countries
Recent news and posts
Ongoing assessments by the TLV in Sweden
The Swedish Dental and Pharmaceutical Benefits Agency (TLV) performs national health technology assessments (with a heavy focus on health economic evaluation) as part of the “Orderly Introduction of Medical Technologies” framework or as stand-alone evaluations.
As of October 2025, the TLV is working on several health technology assessments, including the following Med Tech-related topics:
- Assessment of advanced insulin pumps for adults with type 1 diabetes;
- MR-guided focused ultrasound (MRgFUS) in essential tremor treatment;
- Breast cancer risk‑assessment product (Stratipath Breast).
See the full details in Swedish here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.